Bender Robert & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.49M | Sell |
|
|||||
|
2023
Q4 | $1.42M | Sell |
|
|||||
|
2023
Q3 | $1.61M | Sell |
|
|||||
|
2023
Q2 | $1.81M | Buy |
|
|||||
|
2023
Q1 | $1.93M | Sell |
|
|||||
|
2022
Q4 | $2.01M | Hold |
|
|||||
|
2022
Q3 | $1.99M | Buy |
|
|||||
|
2022
Q2 | $1.93M | Sell |
|
|||||
|
2022
Q1 | $1.85M | Buy |
|
|||||
|
2021
Q4 | $913K | Hold |
|
|||||
|
2021
Q3 | $913K | Buy |
|
|||||
|
2021
Q2 | $1.03M | Buy |
|
|||||
|
2021
Q1 | $870K | Buy |
|
|||||
|
2020
Q4 | $802K | Buy |
|
|||||
|
2020
Q3 | $779K | Buy |
|
|||||
|
2020
Q2 | $748K | Buy |
|
|||||
|
2020
Q1 | $567K | Sell |
|
|||||
|
2019
Q4 | $655K | Sell |
|
|||||
|
2019
Q3 | $526K | Sell |
|
|||||
|
2019
Q2 | $491K | Sell |
|
|||||
|
2019
Q1 | $557K | Sell |
|
|||||
|
2018
Q4 | $612K | Sell |
|
|||||
|
2018
Q3 | $756K | Hold |
|
|||||
|
2018
Q2 | $674K | Sell |
|
|||||
|
2018
Q1 | $795K | Sell |
|
|||||
|
2017
Q4 | $777K | Sell |
|
|||||
|
2017
Q3 | $829K | Buy |
|
|||||
|
2017
Q2 | $697K | Sell |
|
|||||
|
2017
Q1 | $708K | Sell |
|
|||||
|
2016
Q4 | $822K | Buy |
|
|||||
|
2016
Q3 | $743K | Buy |
|
|||||
|
2016
Q2 | $987K | Sell |
|
|||||
|
2016
Q1 | $888K | Sell |
|
|||||
|
2015
Q4 | $983K | Buy |
|
|||||
|
2015
Q3 | $779K | Buy |
|
|||||
|
2015
Q2 | $791K | Buy |
|
|||||
|
2015
Q1 | $750K | Buy |
|
|||||
|
2014
Q4 | $624K | Buy |
|
|||||
|
2014
Q3 | $515K | Sell |
|
|||||
|
2014
Q2 | $497K | Sell |
|
|||||
|
2014
Q1 | $22.5K | Sell |
|
|||||
|
2013
Q4 | $560K | Sell |
|
|||||
|
2013
Q3 | $499K | Buy |
|
|||||
|
2013
Q2 | $476K | Buy |
|